# clm_14D79C128253

subject: Amgen (/record/amgen.md)  
predicate: operating_income  
value: 7,258,000,000 United States dollar  
valid_from: 2024-12-31  
valid_to: 2025-12-31  
published: 2025-02-14  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_92AC0DE5846F  
last_updated: 2026-11-08  
cite: AsOf. "Amgen operating income: 7,258,000,000 United States dollar", as of 2024-12-31 (until 2025-12-31). Claim clm_14D79C128253, https://asof.is/claim/clm_14D79C128253, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-02-14  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm (primary, SEC EDGAR 10-K FY2024, published 2025-02-14)

## Supersedes

- [Amgen](/record/amgen.md) | operating_income | 7,897,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_14D79C128253](/claim/clm_14D79C128253.md) | [clm_D213C7365716](/claim/clm_D213C7365716.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.